Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
Read More

Reported Late Monday, Graybug And CalciMedica Enter Into Definitive Merger Agreement To Combine The Companies In An All-Stock Transaction; The Combined Company Will Focus On Further Developing CalciMedica’s Lead Product Candidate Auxora

– Merger to create Nasdaq-listed, clinical-stage biopharmaceutical company focused on advancing CalciMedica's pipeline of first-in-class product candidates for life-threatening inflammatory

GRAY